Company intelligence
Cellply
Unravelling immune system function, one cell at a time
About Cellply
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
Verified activity
Signals from Cellply
3 published signals
People
Cellply appointed Alex Jones as Chief Executive Officer effective August 1, 2026.
Reported by Cellply
Presence & Recognition
Cellply employee Priyanka Dutta Passecker MBA, Ph.D., took the stage to share insights on single-cell technologies for understanding immune function in pediatric hematology and oncology research at the 3rd Pediatric Hematology & Oncology Conference in Kuwait City.
Reported by Cellply
Presence & Recognition
Cellply announced that CBO Priyanka Dutta Passecker will speak at the 3rd Pediatric Hematology & Oncology Conference in Kuwait City.
Reported by Cellply